NFKB1 and breast cancer: Although researches on ISA in the field of inflammation did not show the effects of ISA on MAPK, the inhibition of p38 MAPK (Wang et al., 2016), as well as NF-κB, in breast cancers, may probable be extrapolated to inflammatory cells, especially considering that breast cancer is closely associated with inflammation.